Annual CFF
-$4.80 M
-$21.26 M-129.19%
31 December 2023
Summary:
Journey Medical annual cash flow from financing activities is currently -$4.80 million, with the most recent change of -$21.26 million (-129.19%) on 31 December 2023. During the last 3 years, it has fallen by -$4.32 million (-886.45%). DERM annual CFF is now -101.04% below its all-time high of $462.52 million, reached on 31 December 2017.DERM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$294.00 K
-$5.33 M-105.84%
30 September 2024
Summary:
Journey Medical quarterly cash flow from financing activities is currently -$294.00 thousand, with the most recent change of -$5.33 million (-105.84%) on 30 September 2024. Over the past year, it has increased by +$10.68 million (+97.32%). DERM quarterly CFF is now -100.92% below its all-time high of $31.80 million, reached on 31 December 2021.DERM Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$25.58 M
+$10.68 M+71.70%
30 September 2024
Summary:
Journey Medical TTM cash flow from financing activities is currently $25.58 million, with the most recent change of +$10.68 million (+71.70%) on 30 September 2024. Over the past year, it has increased by +$48.65 million (+210.92%). DERM TTM CFF is now -53.48% below its all-time high of $54.99 million, reached on 31 March 2022.DERM TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DERM Cash From Financing Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -129.2% | +97.3% | +210.9% |
3 y3 years | -886.5% | -102.6% | +20.6% |
5 y5 years | -113.6% | - | - |
DERM Cash From Financing High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -109.1% | at low | -100.9% | +97.8% | -53.5% | +210.9% |
5 y | 5 years | -109.1% | at low | -100.9% | +97.8% | -53.5% | +210.9% |
alltime | all time | -101.0% | at low | -100.9% | +97.8% | -53.5% | +210.9% |
Journey Medical Cash From Financing History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$294.00 K(-105.8%) | $25.58 M(+71.7%) |
June 2024 | - | $5.03 M(+207.3%) | $14.90 M(-562.9%) |
Mar 2024 | - | $1.64 M(-91.5%) | -$3.22 M(-33.0%) |
Dec 2023 | -$4.80 M(-129.2%) | $19.21 M(-275.0%) | -$4.80 M(-79.2%) |
Sept 2023 | - | -$10.98 M(-16.1%) | -$23.07 M(+186.3%) |
June 2023 | - | -$13.09 M(<-9900.0%) | -$8.06 M(-256.7%) |
Mar 2023 | - | $52.00 K(-94.5%) | $5.14 M(-68.8%) |
Dec 2022 | $16.46 M(-69.0%) | $948.00 K(-76.5%) | $16.46 M(-65.2%) |
Sept 2022 | - | $4.03 M(+3531.5%) | $47.31 M(-13.2%) |
June 2022 | - | $111.00 K(-99.0%) | $54.49 M(-0.9%) |
Mar 2022 | - | $11.37 M(-64.3%) | $54.99 M(+3.7%) |
Dec 2021 | $53.02 M | $31.80 M(+183.6%) | $53.02 M(+149.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2021 | - | $11.21 M(+1720.0%) | $21.22 M(+112.0%) |
June 2021 | - | $616.00 K(-93.4%) | $10.01 M(+6.6%) |
Mar 2021 | - | $9.39 M | $9.39 M |
Dec 2020 | -$487.00 K(-86.3%) | - | - |
Dec 2019 | -$3.55 M(-110.0%) | - | - |
Dec 2018 | $35.38 M(-92.4%) | - | - |
Dec 2017 | $462.52 M(+232.9%) | - | - |
Dec 2016 | $138.95 M(+35.0%) | - | - |
Dec 2015 | $102.93 M(-40.9%) | - | - |
Dec 2014 | $174.10 M(+557.5%) | - | - |
Dec 2013 | $26.48 M(+119.5%) | - | - |
Dec 2012 | $12.06 M | - | - |
FAQ
- What is Journey Medical annual cash flow from financing activities?
- What is the all time high annual CFF for Journey Medical?
- What is Journey Medical annual CFF year-on-year change?
- What is Journey Medical quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Journey Medical?
- What is Journey Medical quarterly CFF year-on-year change?
- What is Journey Medical TTM cash flow from financing activities?
- What is the all time high TTM CFF for Journey Medical?
- What is Journey Medical TTM CFF year-on-year change?
What is Journey Medical annual cash flow from financing activities?
The current annual CFF of DERM is -$4.80 M
What is the all time high annual CFF for Journey Medical?
Journey Medical all-time high annual cash flow from financing activities is $462.52 M
What is Journey Medical annual CFF year-on-year change?
Over the past year, DERM annual cash flow from financing activities has changed by -$21.26 M (-129.19%)
What is Journey Medical quarterly cash flow from financing activities?
The current quarterly CFF of DERM is -$294.00 K
What is the all time high quarterly CFF for Journey Medical?
Journey Medical all-time high quarterly cash flow from financing activities is $31.80 M
What is Journey Medical quarterly CFF year-on-year change?
Over the past year, DERM quarterly cash flow from financing activities has changed by +$10.68 M (+97.32%)
What is Journey Medical TTM cash flow from financing activities?
The current TTM CFF of DERM is $25.58 M
What is the all time high TTM CFF for Journey Medical?
Journey Medical all-time high TTM cash flow from financing activities is $54.99 M
What is Journey Medical TTM CFF year-on-year change?
Over the past year, DERM TTM cash flow from financing activities has changed by +$48.65 M (+210.92%)